Nonthermal Atmospheric Pressure Plasma Technology in Dermatology
Main Article Content
Keywords
dermatology, technology, plasma, pediatrics
Abstract
Nonthermal atmospheric plasma (NTAP), also known as cold atmospheric plasma (CAP), is an emerging tool with important effects on biological systems. NTAP harnesses physical plasma, generating a low energy ion environment in which reactive oxygen and nitrogen species are formed. These ionic species can modify proteins and cell membranes in a non-invasive manner. The use of NTAP therapy, a technology once used for medical sterilization, is rapidly expanding, particularly in the field of dermatology. In addition to potent anti-microbial properties, NTAP has demonstrated promise in skin regeneration and cancer-related indications. NTAP affords a unique advantage to pharmacological therapies in that there is no risk of drug-drug interactions. A preliminary safety profile for NTAP has been established, with no adverse effects such as pain, inflammation, blistering, bruising, and pruritus noted to date. In this review, we discuss the clinical application of NTAP in the treatment of onychomycosis, warts, actinic keratosis, and wound healing.
References
2. Dobrynin D, Fridman G, Friedman G, Fridman A. Physical and biological mechanisms of direct plasma interaction with living tissue. New Journal of Physics. 2009;11.
3. Choi JS, Park I, Lee SJ, Ju HJ, Lee H, Kim J. Serum Procollagen Type I N-Terminal Propeptide and Osteocalcin Levels in Korean Children and Adolescents. Yonsei Med J. 2019;60(12):1174-1180.
4. Fluhr JW, Sassning S, Lademann O, et al. In vivo skin treatment with tissue-tolerable plasma influences skin physiology and antioxidant profile in human stratum corneum. Exp Dermatol. 2012;21(2):130-134.
5. Lademann J, Richter H, Alborova A, et al. Risk assessment of the application of a plasma jet in dermatology. J Biomed Opt. 2009;14(5):054025.
6. Morfill G, Kong M, Zimmermann J. Focus on Plasma Medicine. New Journal of Physics. 2009;11.
7. Ermolaeva SA, Petrov OF, Naroditsky BS, Fortov VE, Morfill GE, Gintsburg AL. 10.18 - Cold Plasma Therapy. In: Brahme A, ed. Comprehensive Biomedical Physics. Oxford: Elsevier; 2014:343-367.
8. Choi JH, Song YS, Song K, Lee HJ, Hong JW, Kim GC. Skin renewal activity of non-thermal plasma through the activation of beta-catenin in keratinocytes. Sci Rep. 2017;7(1):6146.
9. Averett C, Arora S, Zubair H, Singh S, Bhardwaj A, Singh AP. Chapter Nine - Molecular Targets of Honokiol: A Promising Phytochemical for Effective Cancer Management. In: Bathaie SZ, Tamanoi F, eds. The Enzymes. Vol 36. Academic Press; 2014:175-193.
10. Schneider C, Gebhardt L, Arndt S, et al. Cold atmospheric plasma causes a calcium influx in melanoma cells triggering CAP-induced senescence. Sci Rep. 2018;8(1):10048.
11. Miller V, Lin A, Fridman G. Plasma stimulation of migration of macrophages. Plasma Process Polym. 2014;11:1193 - 1997.
12. Friedman PC, Miller V, Fridman G, Lin A, Fridman A. Successful treatment of actinic keratoses using nonthermal atmospheric pressure plasma: A case series. J Am Acad Dermatol. 2017;76(2):349-350.
13. Bulson JM, Liveris D, Derkatch I, et al. Non-thermal atmospheric plasma treatment of onychomycosis in an in vitro human nail model. Mycoses. 2020;63(2):225-232.
14. Fridman G, Friedman G, Gutsol A, Shekhter A, Vasilets V, Fridman A. Applied Plasma Medicine. Plasma Process Polym. 2008;5:503-533.
15. Nonsenko T, Shimizu T, Morfill G. Designing plasmas for chronic wound disinfection. New Journal of Physics. 2009;11.
16. Isbary G, Morfill G, Schmidt HU, et al. A first prospective randomized controlled trial to decrease bacterial load using cold atmospheric argon plasma on chronic wounds in patients. Br J Dermatol. 2010;163(1):78-82.
17. Isbary G, Heinlin J, Shimizu T, et al. Successful and safe use of 2 min cold atmospheric argon plasma in chronic wounds: results of a randomized controlled trial. Br J Dermatol. 2012;167(2):404-410.
18. Daeschlein G, Scholz S, Ahmed R, et al. Cold plasma is well-tolerated and does not disturb skin barrier or reduce skin moisture. J Dtsch Dermatol Ges. 2012;10(7):509-515.
19. Brehmer F, Haenssle HA, Daeschlein G, et al. Alleviation of chronic venous leg ulcers with a hand-held dielectric barrier discharge plasma generator (PlasmaDerm(®) VU-2010): results of a monocentric, two-armed, open, prospective, randomized and controlled trial (NCT01415622). J Eur Acad Dermatol Venereol. 2015;29(1):148-155.
20. Isbary G, Koritzer J, Mitra A, et al. Ex vivo human skin experiments for the evaluation of safety of new cold atmospheric plasma devices. Clin Plasma Med. 2013;1:36-44.
21. Emmert S, Brehmer F, Hanble H, et al. Atmospheric pressure plasma in dermatology: Ulcus treatment and much more. Clin Plasma Med. 2013;1:24-29.
22. López M, Calvo T, Prieto M, et al. A Review on Non-thermal Atmospheric Plasma for Food Preservation: Mode of Action, Determinants of Effectiveness, and Applications. Front Microbiol. 2019;10:622.
23. Moelleken M, Jockenhofer F, Wiegand C, Buer J, Benson S, Dissemond J. Pilot study on the influence of cold atmospheric plasma on bacterial contamination and healing tendency of chronic wounds. J Dtsch Dermatol Ges. 2020;18(10):1094-1101.
24. Lipner SR FG, Scher RK. Pilot study to evaluate a plasma device for the treatment of onychomycosis. Clin Exp Dermatol. 2017;42(3):295-298.
25. Friedman PC. Cold atmospheric pressure (physical) plasma in dermatology: where are we today? Int J Dermatol. 2020;59(10):1171-1184.
26. Westerberg DP, Voyack MJ. Onychomycosis: Current trends in diagnosis and treatment. Am Fam Physician. 2013;88(11):762-770.
27. Foley K, Gupta AK, Versteeg S, Mays R, Villanueva E, John D. Topical and device-based treatments for fungal infections of the toenails. Cochrane Database Syst Rev. 2020;1:CD012093.
28. Beck TC, Beck KR, Morningstar J, Benjamin MM, Norris RA. Descriptors of Cytochrome Inhibitors and Useful Machine Learning Based Methods for the Design of Safer Drugs. Pharmaceuticals (Basel). 2021;14(5).
29. Lin A, Truong, B., Pappas, A., Kirifides, L., Oubarri, A., Chen, S., Lin, S., Dobrynin, D., Fridman, G., Fridman, A., Sang, N. and Miller, V. Uniform Nanosecond Pulsed Dielectric Barrier Discharge Plasma Enhances Anti-Tumor Effects by Induction of Immunogenic Cell Death in Tumors and Stimulation of Macrophages. Plasma Process Polym. 2015;12:1392-1399.
30. Fridman G, Peddinghaus, M., Balasubramanian, M. et al. . Blood Coagulation and Living Tissue Sterilization by Floating-Electrode Dielectric Barrier Discharge in Air. Plasma Chem Plasma Process. 2006;26:425–442.
31. Wirtz M, Stoffels I, Dissemond J, Schadendorf D, Roesch A. Actinic keratoses treated with cold atmospheric plasma. J Eur Acad Dermatol Venereol. 2018;32(1):e37-e39.
32. Arisi M, Soglia S, Guasco Pisani E, et al. Cold Atmospheric Plasma (CAP) for the Treatment of Actinic Keratosis and Skin Field Cancerization: Clinical and High-Frequency Ultrasound Evaluation. Dermatol Ther (Heidelb). 2021;11(3):855-866.
33. Koch F, Salva KA, Wirtz M, et al. Efficacy of cold atmospheric plasma vs. diclofenac 3% gel in patients with actinic keratoses: a prospective, randomized and rater-blinded study (ACTICAP). J Eur Acad Dermatol Venereol. 2020;34(12):e844-e846.
34. Friedman PC, Fridman G, Fridman A. Using cold plasma to treat warts in children: A case series. Pediatr Dermatol. 2020;37(4):706-709.
35. Guo S, Dipietro LA. Factors affecting wound healing. J Dent Res. 2010;89(3):219-229.
36. Mirpour S, Fathollah S, Mansouri P, et al. Cold atmospheric plasma as an effective method to treat diabetic foot ulcers: A randomized clinical trial. Sci Rep. 2020;10(1):10440.
37. Ko UH, Choi J, Choung J, Moon S, Shin JH. Physicochemically Tuned Myofibroblasts for Wound Healing Strategy. Sci Rep. 2019;9(1):16070.
38. Dubey SK PS, Alexander A, Agrawal M, Achalla VPK, Pal UN , Pandey MM, Kesharwani P. Cold atmospheric plasma therapy in wound healing. Process Biochemistry. 2022;112:112-123.
39. Chuangsuwanich A, Assadamongkol T, Boonyawan D. The Healing Effect of Low-Temperature Atmospheric-Pressure Plasma in Pressure Ulcer: A Randomized Controlled Trial. Int J Low Extrem Wounds. 2016;15(4):313-319.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation.
Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.
Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.